We’re proud of the value we create for all our stakeholders, and strive to communicate our performance in a clear and timely manner. Download the latest reports, or stay up to date on various metrics of our market performance here. If you have any queries not addressed here, please feel free to get in touch with Investor Relations on our Contact page.
Observe Medical ASA was listed on Oslo Børs 4 November 2019. Our ambition is to provide shareholders, analysts and investors simultaneous access to accurate, clear and relevant information. We aim to make all our communication to the financial market available on this web site.
16 November 2021: The board of directors of Observe Medical ASA (the "Company") has resolved to grant 120,000 share options in the Company to the group CFO, Per Arne Nygård. Per Arne Nygård was engaged as interim CFO of the group as an consultant on 10 December 2019, and was permanently employed as CFO of…
Read moreOslo, November, 3rd, 2021 – Observe Medical ASA (OSE: OBSRV) today released its financial results and presentation of the third quarter of 2021. The Company reports strong revenue growth for the Nordic portfolio, continued progress in the commercialization and go-to-market execution for Sippi® including an update on preparations for US market entry. CEO of Observe Medical,…
Read moreObserve Medical ASA invites you to a presentation of the third quarter 2021. The presentation will take place at Felix Konferansesenter in Oslo on Wednesday, November 3rd. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com – Investor relations and at the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20211103_5/ Representatives from the Company will…
Read moreQuarterly Presentation - Q3 2021
Quarterly Presentation - Q4 2021
Annual Report (publish)
Quarterly Presentation - Q1 2022
Annual General Meeting
Quarterly Presentation - Q2 and First Half Report 2022
Quarterly Presentation - Q3 2022
Last updated 25 October 2021
| Name | Number of shares | % of top 20 | % of total | Country | |
|---|---|---|---|---|---|
| 1 | NAVAMEDIC ASA | 4,222,727 | 25.08% | 21.54% | Norway |
| 2 | INGERØ REITEN INV. COMPANY AS | 3,939,394 | 23.40% | 20.09% | Norway |
| 3 | RO, LARS | 1,501,051 | 8.92% | 7.66% | NORWAY |
| 4 | UBS SWITZERLAND AG | 1,418,522 | 8.43% | 7.24% | SWITZERLAND |
| 5 | ARTAL AS | 1,064,457 | 6.32% | 5.43% | Norway |
| 6 | ALPINE CAPITAL AS | 745,446 | 4.43% | 3.80% | Norway |
| 7 | Soleglad Invest AS | 586,668 | 3.49% | 2.99% | NORWAY |
| 8 | NORDA ASA | 511,632 | 3.04% | 2.61% | NORWAY |
| 9 | TRANBERGKOLLEN INVEST AS | 500,000 | 2.97% | 2.55% | Norway |
| 10 | LEIKERANE AS | 373,439 | 2.22% | 1.90% | Norway |
| 11 | LAPAS AS | 348,326 | 2.07% | 1.78% | Norway |
| 12 | GINNY INVEST AS | 270,030 | 1.60% | 1.38% | NORWAY |
| 13 | PHILIP HOLDING AS | 260,000 | 1.54% | 1.33% | NORWAY |
| 14 | KRAEBER VERWALTUNG GMBH | 214,850 | 1.28% | 1.10% | GERMANY |
| 15 | cam as | 181,000 | 1.08% | 0.92% | NORWAY |
| 16 | mp pENSJON PK | 176,135 | 1.05% | 0.90% | NORWAY |
| 17 | Bjørntvedt, vegard | 148,220 | 0.88% | 0.76% | norway |
| 18 | Nordnet bank ab | 137,101 | 0.81% | 0.70% | sweden |
| 19 | ABC INVEST AS | 120,000 | 0.71% | 0.61% | NORWAY |
| 20 | pettersen, gunerius | 115,013 | 0.68% | 0.59% | Norway |
| Total numBer owned by top 20 | 16,834,011 | 100.00% | 85.86% | ||
| Total number of shares | 19,605,457 |
Stock Exchange:
Ticker:
First day of listing:
Sector:
Trading Currency:
ISIN:
Number of shares issued:
Nominal value:
Euronext Expand Oslo
OBSRV
4 November 2019
Healthcare
NOK
NO0010865009
19 605 457
NOK 0.26
21 May 2021: Minutes from Annual General meeting
30 April 2021: Notice of Annual General Meeting on 21 May 2021
30 April 2021: Notice of attendance and proxy form to the Annual General meeting on 21 May 2021
30 April 2021: The Nomination Committee's recommendation
30 April 2021: Guidelines for determination of salary and other remuneration to executive Personnel
30 June 2020: Annual General Meeting
16 June 2020: Extraordinary General Meeting
9 June 2020: Notice of Annual General Meeting on 30 June 2020
9 June 2020: Attendance to the Annual General Meeting on 30 June 2020
9 June 2020: Recommendation by the Nomination Committee
9 June 2020: The Boards declaration on remuneration to executive management
26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020
26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020
24 October 2019: Extraordinary General Meeting
1 October 2019: Extraordinary General Meeting
5 August 2019: Extraordinary General Meeting
The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.
The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.
For nomination committee please contact:
Bård Brath Ingerø, Chair of the Nomination Committee
+47 92 83 33 34 / bbi@reitenco.no